Strattec Insider Award: 1,704 Restricted Shares and Performance RSUs for SVP
Rhea-AI Filing Summary
Strattec Security Corp (STRT) reported an insider equity award by Becker-Varto Chey, SVP & Chief Commercial Officer. On 08/22/2025 Ms. Chey was granted 1,704 shares of restricted stock that vest pro rata over three years (one-third each on 08/22/2026, 08/22/2027 and 08/22/2028). In addition, she received 1,704 performance restricted stock units tied to the issuer's EBITDA percentage for a three-year performance period ending 07/02/2028; those PRSUs represent contingent rights to receive common stock if performance conditions are met. Following the reported transactions, Ms. Chey beneficially owns 1,704 shares directly. The Form 4 was signed via power of attorney on 08/26/2025.
Positive
- Grant of 1,704 restricted shares with clear vesting dates (08/22/2026, 08/22/2027, 08/22/2028) which supports retention.
- 1,704 performance restricted stock units tied to EBITDA over a three-year period ending 07/02/2028, aligning compensation with company performance.
- Filing executed and signed via power of attorney on 08/26/2025, providing timely disclosure of insider holdings.
Negative
- None.
Insights
TL;DR: Routine, compensation-driven equity grants align executive incentives to multi-year EBITDA performance.
The report documents standard executive compensation instruments: time-based restricted stock and performance-restricted stock units tied to EBITDA over a three-year window. Time-vesting restricted shares provide retention incentives through 2028 while PRSUs link pay to a measurable financial metric, aligning the officer's interests with company profitability targets. The award size (1,704 shares each instrument) appears modest and is typical for non-CEO senior officers, suggesting limited near-term voting or control impact. Documentation and filing via power of attorney are properly executed.
TL;DR: Mix of time-vesting and performance-vesting equity is a common compensation practice to retain and incentivize executives.
The grant combines one-third annual vesting over three years for restricted stock with performance RSUs contingent on EBITDA for the three-year period ending 07/02/2028. This structure balances retention (time-based vesting) with performance alignment (EBITDA hurdle). The Form 4 shows the grants at $0 reported price, reflecting awarded equity rather than market purchase. Beneficial ownership post-grant is shown as 1,704 shares direct, indicating awards have not yet materially changed insider ownership stake disclosure.